National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

OC22 | THE ROLE OF NCX INHIBITION IN NEUROPROTECTION AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY

S. Di Girolamo1, C. Invernizzi1|3, V. Rodriguez-Menendez1, E. Ballarini1, P. Alberti1|2 | 1Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 2Department of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 3PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

The clinical utility of oxaliplatin (OHP), a cornerstone of colorectal cancer treatment, is limited by OHP-induced peripheral neurotoxicity (OIPN), which comprises acute and chronic syndromes. Acute OIPN is characterized by transient axonal hyperexcitability that begins with the first treatment cycle and results from functional alterations in voltage-gated sodium channels (NaV). By contrast, chronic OIPN manifests as a persistent sensory neuronopathy associated with sustained axonal damage (AxD). These syndromes may be mechanistically linked: transient NaV dysfunction increases intraneuronal Na+ concentrations, potentially activating the sodium–calcium exchanger (NCX) in reverse mode. The resulting Na+/Ca2+ exchange may lead to toxic intracellular Ca2+ accumulation and subsequent AxD. We therefore investigated the contribution of NCX to AxD development in an in vitro model of OIPN. Primary dorsal root ganglion (DRG) neuronal cultures derived from male C57BL/6 mice (8–10 weeks old) were examined primarily using the Nanolive CX-A 3D holotomographic microscope, a state-of-the-art live-cell imaging platform. Potential neuroprotective strategies included SEA0400, a potent and selective NCX inhibitor, and small interfering RNAs (siRNAs) targeting NCX2, the isoform most highly expressed in DRG neurons. Exposure to OHP (7.5–25 μM for 48 h) induced dose- and time-dependent neurotoxicity, characterized by neurite fragmentation and markedly reduced cell viability and preceded by autophagic stress and necroptosis. NCX involvement in OIPN was further assessed using the lipid droplets (LDs) count per cell as a label-free holotomographic readout of cellular stress. LDs numbers increased progressively following exposure to both low- and high-dose OHP (7.5 and 25 μM, respectively), reaching approximately 40% above control levels. Immunofluorescence and staining of LDs confirmed this finding. Notably, pretreatment with SEA0400 (1 μM for 3 h) prevented the pathological changes induced by low-dose OHP. Similarly, pretreatment with NCX2-targeting siRNAs (5 nM for 24 h) markedly attenuated OHP-induced alterations by downregulating NCX2 expression. These findings indicate that targeting the NCX family, particularly NCX2, attenuates OIPN-related AxD and may therefore represent a strategy for preventing AxD. This mechanism may also extend beyond OIPN, as axonal hyperexcitability and NCX-mediated Ca2+ toxicity have been implicated in genetic, inflammatory, and metabolic neuropathies.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
OC22 | THE ROLE OF NCX INHIBITION IN NEUROPROTECTION AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY: S. Di Girolamo1, C. Invernizzi1|3, V. Rodriguez-Menendez1, E. Ballarini1, P. Alberti1|2 | 1Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 2Department of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 3PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4816